ALX Oncology (ALXO) Financials: Revenue & Earnings

ALXO price $1.08 -0.01 -1.36%

Ticker
ALXO
Price
$1.08
Change
-0.01 -1.36%
Market cap ?
$150.03M
P/E ?
-1.00
Dividend yield ?
0.00%
Beta ?
0.40
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
59
Quality
47
Growth
100

Stocklytics score rationale: value 59, quality 47, growth 100.

Financials

20182019202020212022202320242025
20670004796000118200000000

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has collaboration agreement for…

Fair value

ALXO fair value Not meaningful. Price $1.08.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ALXO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-06—-0.15——
2026-08-06-0.13-0.14——
2026-05-08-0.17-0.15——
2026-02-27-0.42-0.38——
2025-11-07-0.41-0.37——
2025-08-12-0.49-0.46——
2025-05-08-0.58-0.47——
2025-03-06-0.55-0.72——
2024-11-07-0.58-0.78——
2024-08-08-0.76-0.77——
2024-05-09-0.71-0.87——
2024-03-07-0.93-0.842.48M—
2023-11-13-1.24-0.86——
2023-08-10-0.84-0.85——
2023-05-11-0.58-0.84——
2023-03-09-0.60-0.91——
2022-11-08-0.72-0.75——
2022-08-08-0.67-0.66——
2022-05-09-0.46-0.77——
2022-02-28-0.56-0.63——
2021-11-11-0.51-0.47——
2021-08-12-0.34-0.42——
2021-05-17-0.31-0.46——
2021-03-18-0.44-0.361—
2020-11-12-0.32-0.37——
2020-08-27-3.38-0.33527.00K5.39M
2020-07-17-0.16—655.00K—
2019-12-31-0.35—1.21M—
2019-09-30-0.14—1.26M—
2019-06-30-0.19—1.29M—
2019-03-31-0.19—1.03M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-17Lettmann JasonSell2.23K$1.934.30K
2026-08-17Wong ShellySell573$1.931.11K
2026-07-01Wong ShellySell1.40K$2.042.86K
2026-04-16Knight Jeff E.Buy800.00K$1.681.34M
2026-04-16Klencke BarbaraBuy100.00K$1.68168.00K
2026-04-13Knight Jeff E.Other0——
2026-03-19Lettmann JasonSell12.31K$2.1726.71K
2026-03-19Pinto ShellySell903$2.171.96K
2026-03-03Klencke BarbaraBuy700.00K$2.071.45M
2026-02-25Klencke BarbaraOther0——
2026-02-25Klencke BarbaraOther40.40K$1.6566.66K
2026-02-25Klencke BarbaraOther300.00K$1.05315.00K
2026-02-25Klencke BarbaraOther100.00K$1.48148.00K
2026-02-18Pinto ShellySell565$2.271.28K
2026-02-17Lettmann JasonSell2.20K$2.275.00K
2026-02-02GOODMAN COREY SBuy3.18M$1.575.00M
2026-01-26Shantharam HarishBuy303.00K$1.48448.44K
2026-01-26Pinto ShellyBuy192.00K$1.48284.16K
2026-01-26Lettmann JasonBuy912.00K$1.481.35M
2026-01-20GOODMAN COREY SBuy40.40K$1.3253.33K
2026-01-20Garland J. ScottBuy40.40K$1.3253.33K
2026-01-20Sandler Alan B.Buy10.10K$1.3213.33K
2026-01-20Curran Daniel J.Buy16.83K$1.3222.22K
2026-01-20Takimoto Chris HBuy40.40K$1.3253.33K
2026-01-20Hemrajani RekhaBuy40.40K$1.3253.33K
2026-01-06Pinto ShellySell3.92K$1.114.36K
2025-10-14Pinto ShellyBuy140.00K$1.70238.00K
2025-10-14Lettmann JasonBuy597.50K$1.701.02M
2025-10-14Shantharam HarishBuy198.75K$1.70337.88K
2025-09-17Klencke BarbaraBuy300.00K$1.05315.00K
2025-09-17Lettmann JasonBuy71.16K$1.0876.89K
2025-09-16Lettmann JasonBuy21.07K$1.0722.46K
2025-08-18Shantharam HarishBuy75.00K$0.7858.40K
2025-08-15Pinto ShellySell611$0.64391
2025-08-15Lettmann JasonSell2.38K$0.641.53K
2025-08-12Curran Daniel J.Buy40.40K$0.6124.85K
2025-08-12Curran Daniel J.Other0——
2025-07-07Pinto ShellySell2.01K$0.45905
2025-06-30Pinto ShellySell1.53K$0.43659
2025-04-11Pinto ShellyBuy90.00K$0.4944.10K
2025-04-11Sandler Alan B.Buy125.00K$0.4961.25K
2025-04-11Shantharam HarishBuy125.00K$0.4961.25K
2025-04-11Lettmann JasonBuy125.00K$0.4961.25K
2025-03-14Pinto ShellyBuy3.00K——
2025-03-14Lettmann JasonBuy42.00K——
2025-02-19Pinto ShellySell550$1.15633
2025-02-19Pons JaumeSell1.33K$1.151.53K
2025-02-19Lettmann JasonSell2.16K$1.152.48K
2025-01-21Hemrajani RekhaBuy40.40K$1.6566.66K
2025-01-21Garland J. ScottBuy40.40K$1.6566.66K
2025-01-21GOODMAN COREY SBuy40.40K$1.6566.66K
2025-01-21Takimoto Chris HBuy40.40K$1.6566.66K
2025-01-21Takimoto Chris HOther0——
2025-01-21Klencke BarbaraBuy40.40K$1.6566.66K
2025-01-21Klencke BarbaraOther0——
2025-01-21Shantharam HarishBuy600.00K$1.65990.00K
2025-01-21Shantharam HarishOther0——
2025-01-21Pinto ShellyBuy112.00K$1.65184.80K
2025-01-21Sandler Alan B.Buy100.00K$1.65165.00K
2025-01-21Pons JaumeBuy50.00K$1.6582.50K
2025-01-21Lettmann JasonBuy478.00K$1.65788.70K
2025-01-06Pinto ShellySell2.22K$1.804.00K
2024-12-30Pinto ShellySell1.43K$1.582.25K
2024-12-30Pons JaumeSell10.80K$1.5817.06K
2024-12-02Hemrajani RekhaBuy30.00K$1.5546.40K
2024-12-02Pinto ShellyBuy150.00K$1.66249.00K
2024-12-02Lettmann JasonBuy200.00K$1.66332.00K
2024-11-18Sandler Alan B.Buy600.00K$1.22732.00K
2024-08-14Pinto ShellySell564$2.581.46K
2024-08-14Randolph SophiaSell1.36K$2.583.52K
2024-08-14GARCIA PETER SSell761$2.581.96K
2024-08-14Pons JaumeSell1.94K$2.585.00K
2024-08-14Lettmann JasonSell2.19K$2.585.65K
2024-08-05Sandler Alan B.Buy40.40K$2.73110.29K
2024-08-05Sandler Alan B.Other0——
2024-07-11Pons JaumeBuy20.00K$0.9919.80K
2024-07-11Pons JaumeSell20.00K$7.90158.08K
2024-07-11Pons JaumeSell20.00K$0.9919.80K
2024-07-05Pinto ShellySell1.82K$5.5010.03K
2024-07-01Pinto ShellySell1.37K$5.827.99K
2024-07-01Randolph SophiaSell3.27K$5.8219.04K
2024-07-01Pons JaumeSell10.76K$5.8262.60K
2024-06-28GARCIA PETER SSell1.79K$6.0310.79K
2024-06-13GARCIA PETER SBuy12.00K$8.53102.34K
2024-06-13Hemrajani RekhaBuy20.20K$8.44170.49K
2024-06-13Garland J. ScottBuy20.20K$8.44170.49K
2024-06-13GOODMAN COREY SBuy20.20K$8.44170.49K
2024-06-04Pons JaumeBuy20.00K$0.9919.80K
2024-06-04Pons JaumeSell20.00K$8.43168.65K
2024-06-04Pons JaumeSell20.00K$0.9919.80K
2024-05-13Randolph SophiaSell10.20K$15.82161.38K
2024-05-13Randolph SophiaSell1.80K$16.6729.96K
2024-05-06Pons JaumeBuy20.00K$0.9919.80K
2024-05-06Pons JaumeSell20.00K$15.92318.33K
2024-05-06Pons JaumeSell20.00K$0.9919.80K
2024-04-16Pons JaumeBuy25.85K$0.9925.59K
2024-04-16Pons JaumeSell50.00K$14.20710.20K
2024-04-16Pons JaumeSell25.85K$0.9925.59K
2024-04-04Pons JaumeSell20.00K$11.15223.04K
2024-03-14Lettmann JasonBuy4.40K$11.3149.77K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 98, holders +26 vs prior quarter. Ownership 77.73%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.13.01M00.00%26.93M
VENBIO PARTNERS LLC12.88M00.00%26.67M
BLACKROCK, INC.7.40M6.95M+1552.42%15.32M
REDMILE GROUP, LLC7.39M-571.68K-7.18%15.30M
BLACKSTONE INC.6.59M767.00K+13.16%13.65M
DRIEHAUS CAPITAL MANAGEMENT LLC6.03M290.62K+5.07%12.47M
SILVERARC CAPITAL MANAGEMENT, LLC5.74M5.74MNew11.89M
TCG CROSSOVER MANAGEMENT, LLC5.66M-7.36M-56.54%11.71M
VANGUARD CAPITAL MANAGEMENT LLC4.97M793.70K+18.99%10.30M
VIVO CAPITAL, LLC3.18M00.00%6.59M
MARSHALL WACE, LLP3.07M-685.72K-18.25%6.36M
5AM VENTURE MANAGEMENT, LLC3.06M00.00%6.33M
ALMITAS CAPITAL LLC2.94M-235.40K-7.42%6.08M
ORBIMED ADVISORS LLC2.87M00.00%5.93M
GEODE CAPITAL MANAGEMENT, LLC2.79M2.29M+464.98%5.77M
TWO SIGMA INVESTMENTS, LP2.18M590.34K+37.18%4.51M
MILLENNIUM MANAGEMENT LLC1.54M1.54MNew3.20M
STATE STREET CORP1.50M1.32M+752.48%3.10M
ACADIAN ASSET MANAGEMENT LLC1.31M212.47K+19.30%2.71M
JPMORGAN CHASE & CO1.04M1.04M+1055180.81%2.30M
NORTHERN TRUST CORP935.67K798.71K+583.15%1.94M
ENSIGN PEAK ADVISORS, INC810.30K-140.25K-14.75%1.68M
NANTAHALA CAPITAL MANAGEMENT, LLC750.00K750.00KNew1.55M
VANGUARD PORTFOLIO MANAGEMENT LLC749.23K651.35K+665.45%1.55M
VANGUARD FIDUCIARY TRUST CO743.49K449.01K+152.48%1.54M

Earnings and financials

ALX Oncology Holdings Inc. (ALXO) trades at $1.08, with a market cap of $150.03M and a trailing P/E of -1.00. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
20670004796000118200000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

ALX Oncology (ALXO) Financials: Revenue & Earnings

ALXO$1.08-0.01 -1.36%

$150.03M

Market Cap

-1.00

P/E

—

Forward P/E

69

Score

Price History